Alternative uses for co-products: Harnessing the potential of valuable compounds from meat processing chains by Mullen, Anne Maria et al.
 
 
 
 
 
 
 
 
 
 
 
TITLE Alternative uses for co-products: Harnessing the potential of valuable 
compounds from meat processing chains 
 
AUTHORS Anne Maria Mullen, Carlos Álvarez, Dimitrios I. Zeugolis, Maeve 
Henchion, Eileen O'Neill, Liana Drummond 
 
 
 
 
 
 
 
 
 
This article is provided by the author(s) and Teagasc T-Stór in accordance 
with publisher policies. 
 
Please cite the published version. 
 
The correct citation is available in the T-Stór record for this article. 
This item is made available to you under the Creative Commons 
Attribution-Non commercial-No Derivatives 3.0 License. 
NOTICE: This is the author’s version of a work that was accepted for 
publication in Meat Science. Changes resulting from the publishing process, 
such as peer review, editing, corrections, structural formatting, and other 
quality control mechanisms may not be reflected in this document. Changes 
may have been made to this work since it was submitted for publication. A 
definitive version was subsequently published in Meat Sciene,2017, Available 
online 3 May 2017, https://doi.org/10.1016/j.meatsci.2017.04.243 
Alternative uses for co-products: Harnessing the potential of valuable compounds from 1 
meat processing chains 2 
 3 
Anne Maria Mullen
1*, 
Carlos Álvarez
1
, Dimitrios I Zeugolis
2,3
, Maeve Henchion
4
, E. 4 
O’Neill5 & Liana Drummond1 5 
 6 
1.- Teagasc Food Research Centre,. Dept of Food Quality and Sensory Science. Ashtown, 7 
Dublin 15, Ireland 8 
2.- Regenerative, Modular & Developmental Engineering Laboratory (REMODEL), 9 
Biomedical Sciences Building, National University of Ireland Galway (NUI Galway), 10 
Galway, Ireland  11 
3. - Science Foundation Ireland (SFI) Centre for Research in Medical Devices (CÚRAM), 12 
Biomedical Sciences Building, National University of Ireland Galway (NUI Galway), 13 
Galway, Ireland.  14 
4.- Teagasc Food Research Centre. Dept Agrifood Business and Spatial Analysis. Ashtown, 15 
Dublin 15, Ireland. 16 
5.- University College Cork, Department of Food & Nutritional Sciences, Cork, Dublin 17 
 18 
 19 
 20 
 21 
*Corresponding author: Anne.mullen@teagasc.ie. Tel: + 00 35318059521 22 
Teagasc Food Research Centre, Ashtown, Dublin 15, Ireland 23 
 24 
 25 
Abstract  26 
Opportunities for exploiting the inherent value of protein-rich meat processing co-products, 27 
in the context of increased global demand for protein and for sustainable processing systems, 28 
are discussed. While direct consumption maybe the most profitable route for some, this 29 
approach is influenced greatly by local and cultural traditions. A more profitable and 30 
sustainable approach may be found in recognizing this readily available and under-utilized 31 
resource can provide high value components, such as proteins, with targeted high value 32 
functionality of relevance to a variety of sectors. Applications in food & beverages, petfood 33 
biomedical and nutrition arenas are discussed. Utilization of the raw material in its entirety is 34 
a necessary underlying principle in this approach to help maintain minimum waste 35 
generation. Understanding consumer attitudes to these products, in particular when used in 36 
food or beverage systems, is critical in optimizing commercialization strategies.  37 
 38 
Highlights  39 
- Opportunities for extracting additional value from meat processing chain  40 
- Meat co-products excellent source of proteins, vitamins, minerals and bio-actives 41 
-High added-value uses can be developed to revalorize co-products 42 
 43 
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1. Introduction 48 
Global pressures for increased supply of foods with high protein content, coupled with the 49 
ever increasing demand for more efficient processing and increased financial rewards, 50 
provides the imperative for the food industry to examine all processing streams with a view 51 
to adding or recovering value.  Based on its amino acid profile, animal protein can provide a 52 
complete protein with a high biological value. In addition, meat, and in particular red meat, 53 
provides a rich source of macro and micro-nutrients.  Demand for this high quality product is 54 
expected to continue to expand (FAO, 2009), which will lead to the increased production of 55 
the lower value ‘non meat’ products such as offal, blood, etc., which have been estimated to 56 
account for approximately 54-56% of the bovine and 48% of the porcine live animal weight 57 
(Marti, Johnson, & Mathews Jr, 2012; Vernooij, 2012). In this review, such non-meat 58 
products are referred to as co-products, similar to the view adopted in Australia. 59 
Classification as animal by-products (ABPs) is not always relevant as this classification under 60 
European legislation would restrict the use of these parts in the human food chain. While 61 
many countries have secured markets for them, in general these tend to be low value markets, 62 
often necessitating substantial transport costs. Even more, some of the products will carry a 63 
neutral (no disposal cost) or negative (costs money to dispose of) value. Making better use of 64 
the many co-products arising from meat processing, is not only important from a 65 
sustainability perspective, but also offers opportunities to the industry to increase their value.  66 
As discussed by many authors (Lynch, Mullen, O'Neill, & Álvarez, 2017; Mullen, Álvarez, 67 
Pojić, Hadnadev, & Papageorgiou, 2015; Toldrá, Mora, & Reig, 2016) many of the materials 68 
are rich sources of valuable components such as protein, lipids, biomolecules etc. While some 69 
products command a reasonable value, and provide a nutritious food (Jayathilakan, Sultana, 70 
Radhakrishna, & Bawa, 2012) when consumed directly, for others it may be more valuable to 71 
extract separate components for discreet downstream applications. A five-stage universal 72 
recovery process was suggested by Galanakis (2012) to describe this process of transforming 73 
raw material into a final higher value product. While some of these steps can be eliminated or 74 
merged this gives a good overview of the process. Both traditional and emerging technologies 75 
of relevance are discussed in a later section. Optimal exploitation brings many challenges 76 
such as product hygiene and stabilisation, economies of scale, product purity, consumer 77 
attitudes and the requirement for efficient processing, which minimises the impact on the 78 
environment. These challenges can be addressed both through good industry practice and an 79 
applied research approach. Important principles to be guided by include that of total 80 
exploitation, avoiding the generation of additional waste (Waldron, 2007), and the cascading 81 
principle within the bioencomy discourse which is about ensureing the highest value is 82 
extracted first with lower value options only considred once the higher ones have been 83 
exhausted.  84 
Encouraging optimal utilisation of raw materials, early in the production chain, can help 85 
ameliorate food waste losses before the product becomes more dispersed along the food 86 
chain. The search for alternative protein sources has advanced in recent years (Van Huis et 87 
al., 2013), and provides a relevant approach to meeting global protein requirements. 88 
However, it is imperative to recognise that we have a readily available and under-utilised 89 
resource ripe for exploitation in co-products arising from meat processing.  As there is a link 90 
between meat consumption and demand for protein-rich feed for livestock (Pimentel & 91 
Pimentel, 2003; Trostle, 2008), it is imperative that all meat processing related proteins are 92 
optimally exploited. This review covers applications relating to use in food and beverage 93 
systems, petfood, nutrition focused and bioactive & biomedical applications. Market and 94 
legislative information is provided in additional to an overview of relevant technologies and 95 
consumer attitudes.  96 
 97 
2. Applications 98 
2.1 Food ingredients  99 
Among other attributes proteins can impart techno-functional properties within a food or 100 
beverage system. For example they may influence water holding capacity, viscosity, gelation, 101 
emulsification and foaming. The ability of proteins to function in this manner is determined 102 
by intrinsic e.g. amino acid profile, molecular structure and surface hydrophobicity, and by 103 
extrinsic factors such as pH temperature, and ionic strength. Collagen, a fibrous, structural 104 
protein, is one of the most abundant proteins.  It is probably the animal protein most regularly 105 
employed in food production. Following extraction and hydrolysis it can be transformed into 106 
gelatine whose strong gelling properties are relevant to a variety of products such as soups, 107 
gravies, desserts or dairy products (Hettiarachchy, Sato, Marshall, & Kannan, 2012).  108 
Gelatine is mainly extracted from skin and bones. However, other offal such as lung, tongue, 109 
trachea, large blood vessels, or tendons are, also, sources of collagen.  Collagen has very 110 
good film forming capacity which is exploited to generate casings and novel packaging 111 
(Gómez-Guillén, Giménez, López-Caballero, & Montero, 2011). Other more specific 112 
applications of collagen are described below in section 2.4, and have also been reviewed by 113 
various authors (Ferraro, Anton, & Santé-Lhoutellier, 2016; Zeugolis, Paul, & Attenburrow, 114 
2009). A variety of commercial collagen based products are available for use in food systems. 115 
Examples of companies supplying them include Rousselot, Collapro and Devro, who provide 116 
both clean label binders, gelling and textural agents or collagen based sausage casing. 117 
Blood plasma comes second in line in meat co-product derived protein most employed as a 118 
food ingredient. Following hygienic collection, centrifugation leads to the recovery of plasma 119 
and cellular fractions (Lynch et al., 2017). Plasma can be used as it is, or dehydrated for 120 
storage as a dry powder (Pares, Toldra, Saguer, & Carretero, 2014). Blood plasma is a 121 
versatile product, which presents good emulsifying, gelling, foaming and solubility 122 
properties. Applications of plasma in food industry see it used as a binder in meat products, 123 
egg replacers in bakery, protein-rich pasta, fat replacers or even polyphosphate substitute 124 
(Hsieh & Ofori, 2011; Hurtado et al., 2011). Some examples of plasma proteins currently in 125 
the market are: Fibrimex® (purified fibrinogen used as binder), Immunolin® (concentrated 126 
immunoglobulins, which improve the immune system)(Abu-Akkada & Awad, 2015), Myored 127 
(natural red colorant), Vepro 95 HV (purified globin used as emulsifier) or Plasma Powder 128 
FG (plasma with increased content of fibrinogen used as cold binder) (Ofori & Hsieh, 2012). 129 
Apart from those two sources, the use of offal as sources of proteinaceous food ingredients 130 
has not received a lot of research funding.  In the last decade research has been published 131 
describing the extraction and characterisation of functional proteins from various offal such 132 
as: liver (Steen et al., 2016; Zou et al., 2017), lung (Selmane, Christophe, & Gholamreza, 133 
2008), heart (Dewitt, Gomez, & James, 2002), viscera (Bhaskar, Modi, Govindaraju, Radha, 134 
& Lalitha, 2007) or bones. (Linder, Fanni, Parmentier, Sergent, & Phan-Tan-Luu, 1995). 135 
Very few patents, using offal as an ingredient, have been filed in the last 20 years; for 136 
instance a patent filed in 2001 relates the use of offal as an ingredient for cheaper sausages or 137 
burger patties (Van, 2001). But, in spite of the advances generated in food processing, most 138 
of the patents found in the literature are from the 1960’s and 1970’s. 139 
At a very basic, low value level, protein extracts from offal can be used as extender in 140 
processed meat products (Heinz & Hautzinger, 2007). Recently, the use of pork tongue and 141 
pork head meat as sausage ingredients has been reported, with no significant differences in 142 
some quality characteristics compared to controls (Choi, Hwang, et al., 2016). Similar results 143 
were observed when the final products were hamburger patties (Choi, Jeon, et al., 2016). 144 
However, considering the functional properties of many of these proteins, there is a strong 145 
argument to be made for capitalising on this high-value potential to more fully support a 146 
sustainable use of natural resources. It is important to also remember that, as well as 147 
providing proteins with nutritive value or good techno-functional characteristics, these co-148 
products are well established as being rich in minerals and vitamins (Mullen & Álvarez, 149 
2016).  150 
 151 
2.2 Nutritional quality of co-products  152 
Nutritional quality of proteins has traditionally been defined based on the amino acid profile, 153 
and the ability to provide specific patterns of amino acids for protein synthesis as measured 154 
by animal growth or nitrogen balance in humans (Millward, Layman, Tomé, & Schaafsma, 155 
2008). However, a more current definition describes this term as the ability of the protein to 156 
achieve specific metabolic activities. Currently, the objective of protein quality evaluation is 157 
determining the ability of a protein to reach maintenance needs, along with special needs as 158 
growth, pregnancy or lactation (WHO, 2007). The up-to-date method approved for protein 159 
quality determination is the protein digestibility-corrected amino acid score (PDCAAS). In 160 
this method the single most limiting amino acid is identified, when compared to an 161 
appropriate reference pattern, which defines the amino acid score.  According to FAO, 162 
Lysine, Methionine and Tryptophan are the most limiting amino acids in poor protein 163 
sources. Table 1 shows the amount of these three amino acids, the total protein content and 164 
the percentage of essential amino acids in a variety of offal from pork, beef and lamb. It can 165 
be seen that offal, generally, is a good source of essential (namely Ile, Leu, Lys, Met, Phe, 166 
Thr, Trp, Vali) and limiting amino acids. However, offal rich in connective tissue as ears, 167 
feet, or lips, present a lowest protein quality, since connective tissue is mainly composed by 168 
glycine, proline and alanine, which are not essential amino acids (Mullen & Álvarez, 2016).  169 
This lack of essential amino acids can be overcome by tailor blending ingredients to achieve 170 
a balanced amino acid profile in the final product.  171 
Besides proteins, meat co-products can be a good source of minerals (Ca, Fe, Mg, Cu or Se) 172 
or vitamins (niacin, Vit. B12, folate or Vit. C). Heme iron, mainly provided by meat and fish, 173 
is more absorbable that non-heme iron (<15%); and also, although the mechanism is not well 174 
defined, heme iron is more absorbed in the presence of meat, what is known as the “meat 175 
factor” (López & Martos, 2004). Thus, it is worthy to explore if protein derived from offal 176 
can also increase the bioavailability of iron, since they are a good iron source. Finally, the 177 
offal fat content can vary from less than 1% in blood, up to 17% in tongue; with high 178 
contents ofsaturated fatty acids. Among fats, it is important to draw attention to cholesterol 179 
when referring to co-products, as some have high levels of this compound, as for example 180 
kidneys, liver or brain (Mullen & Álvarez, 2016).  181 
It is clear that meat co-products are rich sources of macro and micro-nutrients. Both these raw 182 
materials and various extracts generated from them can be incorporated in products for 183 
targeted end-users such as the elderly, sports-active or dairy intolerant consumers (Montero 184 
Castillo, Ligardo, Alejandro, González, & Cristina, 2015). 185 
 186 
2.3 Bioactive compounds 187 
Bioactive compounds cover both peptides and other biomolecules which exert a 188 
physiological benefit on consumption. Bioactive peptides or biopeptides are defined as short 189 
sequences of 2 to 30 amino acids that exert this effect. These sequences are encrypted in the 190 
parent protein and must be released from the parent protein to have an effect (Di Bernardini, 191 
Harnedy, et al., 2011; Ryan, Ross, Bolton, Fitzgerald, & Stanton, 2011).  In order to release 192 
these encrypted amino acid sequences, three different techniques are employed: enzymatic 193 
hydrolysis by means of commercial proteases (Sarmadi & Ismail, 2010); proteolytic 194 
microorganism; or after fermentation or aging processes (Escudero et al., 2013). After any of 195 
these processes, hundreds of peptides are generated, but only a few of them show biological 196 
activity. For this reason, a further purification step must be carried out. Techniques such as 197 
membrane filtration, chromatography or differential precipitation are commonly employed 198 
(Power, Fernández, Norris, Riera, & FitzGerald, 2014). A different approach is to firstly 199 
isolate the proteins, and then, carry out the hydrolysis step, which makes the further isolation 200 
process easier. In order to optimise the screening process for bioactive peptide searching, in 201 
silico tools can be employed (Fu et al., 2016): these are useful to find the right 202 
protein/enzyme combination. As a complementary tool,  the peptides of interest can be 203 
synthesized at lab scale, in such way further studies of toxicology, functionality, absorption, 204 
bioavailability or dose response can be performed (Korhonen & Pihlanto, 2006).  205 
As discussed, the main component of meat co-products, on a dry basis, is protein; thus, these 206 
by-products are a potential source of bioactive peptides which can be extracted, purified and 207 
commercialised as a very high-added value product (Lemes et al., 2016).  An ideal scenario is 208 
one where proteins with key techno-functional characteristics are first extracted from the raw 209 
material and the residual proteinaceous material subjected to biopeptide generation. An 210 
example of this is seen on the ReValueProtein project (Álvarez, Lynch, Drummond, & 211 
Mullen, 2016) where techno-functional proteins are extracted from lung and the non-212 
solubilised material used to generate bioactive peptides. Compared to other source materials 213 
relatively few studies have looked at generating bioactive peptides from meat co-products.  214 
Examples of bioactive peptides obtained from blood and meat are published or reviewed by 215 
(Bah, Bekhit, Carne, & McConnell, 2013; Di Bernardini, Harnedy, et al., 2011; Toldra, 216 
Aristoy, Mora, & Reig, 2012). However, a more limited number of studies can be found 217 
using offal as a source (Di Bernardini, Rai, et al., 2011; Lee et al., 2010; O'Sullivan, Lafarga, 218 
Hayes, & O'Brien, 2016). The types of activities reported have included antioxidant, 219 
antimicrobial, antihypertensive, anti-diabetic, anti-hypercholesterolemic or mineral binding 220 
(Sharma, Singh, & Rana, 2011). A number of important points need to be addressed to fully 221 
capitalise on the value of these peptides. Ensuring that the peptides reach the target organ, are 222 
non-toxic and both bioavailable and bioactive in the body is critical. The scale of processing 223 
and the economic feasibility of same are also key considerations: which can be somewhat 224 
mitigated by readily available, low price raw materials combined with novel hydrolysis and 225 
purification steps (Agyei & Danquah, 2011).  226 
Other molecules of interest, as health promoting compounds include creatine, carnosine, 227 
carnitine, anserine and taurine. These naturally occurring low molecular weight molecules 228 
can be found mainly in skeletal muscles and have many positive effects as: antioxidant, 229 
lowering cholesterol, improved calcium absorption, preventing muscle myopathy, or 230 
preventing heart disease (Williams, 2007) hence exudate and cook-out may be good sources. 231 
It has also been reported that heart or liver can be a good source of these compounds 232 
(Hoffmann, Waszkiewicz-Robak, & Świderski, 2010). Though not the subject of this review, 233 
many other active compounds can be found in meat and may also be present in co-products, 234 
such as: conjugated linoleic acid (CLA), chondroitin sulphate, Coenzyme Q10, espermidine, 235 
choline, lipoic acid, or glutathione (Arihara & Ohata, 2008). The main biological activities 236 
are summarized in Table 2. 237 
 238 
2.4 Biomedical applications 239 
Natural biomaterials such as collagen present many opportunities outside of food sector and 240 
in particular can serve as raw materials in biomedical applications. The term ‘collagen’ 241 
encompasses a family of glycoproteins that are characterised by a repeating [Glycine-X-Y]n 242 
amino acid sequence (X is usually proline and Y is frequently hydroxyproline). To-date, 243 
twenty-nine genetically distinct collagen types have been described that can be classified in 244 
four broad categories [fibrous (e.g. types I, II, III), non-fibrous (e.g. types IV, VII, XXVIII), 245 
filamentous (e.g. types VI, VIII, X) and fibril associated with interrupted triple helices (e.g. 246 
types IX, XII, XIV) collagens], based on their primary structure, molecular weight, charge 247 
profile along the helix, length of the triple helix, size and shape of the terminal globular 248 
domains. In vertebrates, collagen is the major constituent of connective tissues, comprising 249 
almost 25 % of total body proteins, 75 % of the dry weight of skin, 80 % of the organic 250 
matter in bones and 90 % of tendon and corneal tissues. The abundance of this extracellular 251 
matrix protein, in addition to its inherent bioactivity, molecular recognition signals, 252 
controllable mechanical and degradation properties and its ability to be reconstructed in 253 
various three-dimensional architectures (e.g. fibres, sponges, films, spheres, hydrogels), make 254 
it an ideal raw material for biomaterials, tissue engineering and drug / gene / cell delivery 255 
applications (Abbah et al., 2015; Kielty & Grant, 2002; Sorushanova et al., Submitted; 256 
Thomas et al., 2016). 257 
In biomedicine, porcine and bovine skin and tendon tissues are the main source of collagen 258 
type I, whilst collagen type II is extracted from porcine and bovine articular cartilage. Fish 259 
industry by-products (e.g. skin, scales and bones) have also been used to extract collagen for 260 
the fabrication of biomaterials, but to a smaller extent. Independently of the source (e.g. 261 
mammalian or fish), purified collagens are extracted using primarily dilute acids with or 262 
without enzymes. Dilute acids disassociate mild intermolecular aldimine cross-links, whilst 263 
proteolytic enzymes (e.g. pepsin) are effective even against stable ketoimine bonds, not only 264 
increasing the yield for up to 10 times, but also lowering immune response in patients, 265 
through the removal of the antigenic sequence P-determinant, located at the telo-peptide 266 
regions (Bruckner & Prockop, 1981; Lynn, Yannas, & Bonfield, 2004; D. I. Zeugolis, Paul, 267 
& Attenburrow, 2008). While collagen and collagen-like molecules can be produced using 268 
various cell types, recombinant systems and peptide synthesis, these technologies are still 269 
very expensive, of low yield, and produce unstable collagens. Compared to animal extracted 270 
collagen they have increased susceptibility to proteolytic degradation, restricting their use in 271 
biomedicine (Browne, Zeugolis, & Pandit, 2013; Fichard, Tillet, Delacoux, Garrone, & 272 
Ruggiero, 1997; Frischholz et al., 1998; Myllyharju et al., 1997; Vuorela, Myllyharju, Nissi, 273 
Pihlajaniemi, & Kivirikko, 1997). All these factors support continued expansion of the use of  274 
collagen in the biomedicine, food and cosmetic industry.  275 
  276 
2.5 Pet food and animal feed 277 
As nutritious sources of protein, fat and micronutrients many products are highly suitable for 278 
use in companion animal diets (Cramer et al., 2007; Rivera, 1998). As rich sources of protein 279 
and as a result of regular use in pet food formulations they have been considered a major 280 
contributor to the growth of the pet food industry (Corbin, 1992). In canine diets they provide 281 
good sources of digestible nutrients in particular proteins and fat (Murray et al 1997). 282 
Palatability is an important consideration in pet foods formulation. Co-products can also 283 
serve as palatability enhancers (Boskot, 2009) which will have a direct impact on product 284 
acceptability. The pet food market has seen strong growth with pet humanisation and 285 
premiumisation being considered key drivers. As well as being incorporated into petfoods 286 
these products are also sold in pet stores as treat type products e.g. bone, hides, ears etc. 287 
Animal feeds play an important role in the global food industry as they influence greatly the 288 
ability to produce animals in an economical way. In particular, following rendering, co-289 
products arising from meat processing form an important constituent in animal feeds 290 
(Jayathilakan, Sultana, Radhakrishna, & Bawa, 2012).  291 
 292 
3. Market overview                   293 
The categorization and utilization of a secondary stream as a co-product is dependent on 294 
several factors such as local and export market demands, existing profitable applications and 295 
a favourable and feasible commercialization route. Broadly speaking, depending on local 296 
cultural habits, the market for 5
th
 quarter products such as offal and blood is shared between 297 
exports, pet food, animal feed and local direct consumption. 298 
Clear opportunities for exploring a variety of meat co-products have been identified over the 299 
years in scientific research studies and market trend reports. However, an effective market 300 
analysis of this area needs to take account not only of the latest R&D and scientific advances 301 
in the recovery and reutilization of compounds from co-product materials, but also of 302 
industry activities currently in place, as well as existing market and commercial scenario of 303 
the original products, since re-direction of a stream may have impacts on established supply 304 
chains and ancillary commercialization routes. Several markets with existing or future 305 
potential based on co-products are briefly presented below. 306 
The protein market is generally divided by applications: food and beverage, sports nutrition, 307 
animal feed, cosmetics and personal care, pharmaceuticals, etc. For the sports nutrition 308 
category in particular, protein stands as the main driving force (Schmidt, 2014). In Ireland 309 
and other markets, protein powders are still the most popular type of sports nutrition product, 310 
but other more convenient formats such as protein ready-to-drink products and protein bars 311 
are quickly becoming more popular (Hickey, 2014). As reported by Glanbia “the global 312 
performance nutrition market, at retail selling price, is approximately $10.1 billion with the 313 
USA accounting for 63%, and other international markets accounting for 37%” 314 
(Glanbia.com, 2017). Although whey proteins still dominate this market, due to 315 
diversification of products and applications, blends incorporating other sources of proteins 316 
are increasingly gaining ground. 317 
The market size for functional foods may be difficult to measure, as the exact definition of a 318 
functional food can vary between regions, countries or even companies. Nonetheless, some 319 
analysts value it at up to USD 190 Bn worldwide, showing a growing of 6–25% per year, and 320 
with the same perspective for the next 5 years (Calvo, Martorell, Genovés, & Gosálbez, 321 
2016). 322 
The global collagen market is forecast to expand at a 9.4 % compound annual growth rate 323 
from 2015 to 2023 and the market is projected to rise to US$ 9.37 billion by 2023 ("Collagen 324 
market - Global industry analysis, size, share, growth, trends, and forecast 2015 – 2023," 325 
Transparent Market Research Report 2016). Currently, around 60% is due to gelatine 326 
production (Global Market Insights report, 2015). Other markets which go beyond food and 327 
beverage include the use of collagen for biomedical applications and the manufacture of 328 
advanced biomaterials, for tissue regeneration for example, an area reported to be expanding 329 
rapidly (Global Market Insights report, 2015). Collagen has also attracted much interest as a 330 
source of functional peptides, with applications in the health, cosmetics and personal care 331 
areas.  332 
The challenges in obtaining approval for peptides as ingredients with beneficial health 333 
properties has undoubtedly influenced the growth of this market, but for products which 334 
receive approval there are clear rewards. In 2012 while approved peptide drugs were 335 
estimated to command only about 2% of the global drug market the value represented 336 
approximately USD 20 billion (Sun, 2013). 337 
Key markets for animal blood include the food industry, animal feed and pet food 338 
applications. It is estimated that the food industry utilizes about 30% of blood produced from 339 
slaughter in different forms, for example plasma used as an emulsifier or whole blood used in 340 
traditional products (Bah et al., 2013). The value of the US dried animal blood plasma market 341 
for animal feed in 2010 was estimated in USD 29 million per annum (Wilson, 2011). The 342 
possibility of obtaining bioactive peptides from blood could lead to higher value products 343 
being produced, giving access to the expanding functional and nutraceutical applications 344 
market. Further efforts for the extraction and valorisation of protein from animal blood may 345 
also increase the use of blood as a source of techno-functional compounds for food and 346 
beverage applications. 347 
While the export market for some 5
th
 quarter products offer the greatest opportunity to 348 
increase margins from edible offal, consumer perceptions in relation to food scares or disease 349 
outbreaks may have an unjustifiable impact of product values. Additionally, an understanding 350 
of specific market requirements is necessary, to satisfy demands in terms of customs and 351 
expectations. 352 
 353 
4. Consumer studies 354 
Humans seek novelty and variety in their diet for nutrition and health reasons and to satisfy 355 
pleasure seeking motives (Al-Shawaf, Lewis, Alley & Buss, 2015).  However they are also 356 
wary of foods with which they are unfamiliar, due to fears in relation to food safety and 357 
health.  This led to the phrase “the omnivores dilemma” to reflect individual’s competing 358 
motives of neophobia and neophilia (Martins, Pelchat & Pliner, 1997).  Reflecting differences 359 
in cultures, meat co-products are regarded as delicacies in some countries, however most 360 
consumers in developed countries are unfamiliar with meat co-products, such that many have 361 
never tasted offal and most have a very limited knowledge about how to prepare and cook it.  362 
Some may even regard them as unhealthy or waste (Frewer & Gremmen, 2007).    363 
Three important factors may lead to the rejection of unfamiliar food products: negative 364 
sensory properties, harmful consequences and “ideational” factors (Rozin & Fallon, 1987).  365 
Henchion et al (2016) found such factors at play in consumer evaluations of a range of 366 
product concepts that incorporated ingredients derived from offal.  On the negative side, 367 
consumers were concerned with the taste and texture of such products, did not see significant 368 
benefits, were disgusted with the idea that the ingredients originated in live animals and even 369 
questioned if such products were edible.  However this research also found that processing 370 
could have a positive influence on acceptance through its influence on the physical form of 371 
the ingredient.   Changing the physical form of the ingredient resulted in “de-animalising” the 372 
ingredient and for some consumers shifted the focus away from emotive, ideational factors, 373 
and allowing them to consider the product’s characteristics and benefits. The impact of 374 
processing is however complex with increased processing resulting in negative perceptions 375 
regarding healthiness and naturalness in some contexts. 376 
Integrating unfamiliar foods into existing culinary and dietary practices was identified as 377 
supporting acceptance in the context of insect-based foods (Looy, Dunkel, & Wood, 2014).  378 
Research by Henchion et al (2016) reports similar findings with regards to meat co-products 379 
suggesting that this strategy could also work for meat co-products.  They argue that meat co-380 
products should be presented to consumers as ingredients rather than finished products to 381 
give them flexibility in terms of how they are integrated into consumers’ routines. 382 
The role of experts, celebrity chefs and friends in providing evidence that consumption of 383 
unfamiliar products is safe and socially acceptable is highlighted in relation to meat co-384 
products in some niche markets.  Boutique butchers with traditional “fancy meats” and 385 
restaurants featuring nose-to-tail eating are becoming more prevalent in the UK for example, 386 
resulting in changes in the consumer landscape, with a claim by Datamonitor (2014) that 387 
“offal is officially in”, due to experimentation, consciousness of value and increased 388 
availability. 389 
                       390 
5. Legislation                        391 
To explore and commercialise the range of available co-products of animal origin it is 392 
necessary to understand relevant legislation, rules and regulations governing access to source 393 
materials and markets. Information and guidance on how material is to be collected, handled, 394 
stored, processed, etc. will determine not only the value of the final product, but crucially 395 
ensure compliance for downstream uses. It can be said that legislation was developed for two 396 
distinct groups: unusable and usable by-products (Leoci, 2014). For unusable by-products, 397 
associated regulations lay down handling and disposal rules to safeguard the environment and 398 
public health. On the other hand, for by-products posing no risk to health or the environment, 399 
and for which a viable commercial application exists, regulations may relate to materials’ 400 
collection, transport and further processing. 401 
In the European Union, the term animal by-product (ABP), is reserved for products of animal 402 
origin that are not intended for human consumption and use or disposal of ABP is strictly 403 
controlled. Depending on the risk they pose, ABPs are divided into categories 1, 2 and 3, 404 
category 1 being the highest in risk. The classification of some 5
th
 quarter products as edible 405 
or inedible can be influenced by collection and handling conditions and on local or existing 406 
export markets. If intended for human consumption, 5
th
 quarter products are covered under 407 
regulations for food of animal origin, and should not be classified as ABPs.  408 
Since the bovine spongiform encephalopathy (BSE) crises, rules for the prevention, control 409 
and eradication of certain transmissible spongiform encephalopathies (TSEs) set out in 410 
Regulation 999/2001, have irreversibly excluded parts of the carcass from the food chain. 411 
The regulation covers the production, placing on the market and, in some cases, the export of 412 
animals and animal products. For feed and pet food, for example, only category 3 material is 413 
allowed. Directive 2008/98/EC on waste includes a definition and the main conditions which 414 
must be met by a substance to be classified as a by-product. The regulation encourages the 415 
reuse, reutilization and recycling of non-hazardous by-products. Also relevant, Directive 416 
2008/1/EC prohibits discharging of blood into digesters and sets down an obligation of using 417 
blood for other purposes. 418 
Regulation (EC) No 1069/2009 includes health rules as regards animal by-products and 419 
derived products not intended for human consumption (uses other than for food). However, 420 
some products are not covered by this Regulation. These include cosmetic products 421 
(Directive 76/768/EEC); medical implants (Directive 90/385/EEC); medical devices 422 
(Directive 2003/32/EC); In vitro diagnostic medical devices (Directive 89/79/EC); veterinary 423 
medical products (Directive 2001/82/EC); and medicinal products (Directive 2001/83/EC).   424 
For parts of the carcass intended for human consumption, the "Hygiene Package": Regulation 425 
(EC) 852/2004, Regulation (EC) 853/2004 and Regulation (EC) 854/2004), must apply, as 426 
well as the Regulation (EC) 1169/2011 for the provision of food information to consumers. 427 
From the perspective of food hygiene regulations, offal is defined as: “fresh meat other than 428 
that of the carcass, including viscera and blood” (EC) 854/2004). However, from an 429 
ingredient labelling perspective, Regulation (EC) 1169/2011 restricts the definition of “meat” 430 
to skeletal attached muscles. Any other parts of the animal must be declared separately and 431 
the meat species must be identified on the label (e.g.: “beef heart protein” or “bovine heart 432 
protein”), which can have an impact on consumer perception of these food ingredients.  433 
Also relevant, assuming they are utilised in products for these target audiences, Regulation 434 
(EU) No 609/2013 on food intended for infants and young children, food for special medical 435 
purposes, and total diet replacement for weight control, lays down general rules on the 436 
composition and preparation of foods that are specially designed to meet the particular 437 
nutritional requirements of the persons for whom they are intended. 438 
Regulation 1333/2008 (latest consolidated version published February 2016) covers food 439 
additives and  lists substances that are not considered as additives, and hence not covered by 440 
this regulation, which includes blood plasma, protein hydrolysates and their salts. These are 441 
also not considered meat and must be declared separately on the label. Annex II to Regulation 442 
1333/2008, amended by Regulation (EU) 601/2014, lays down a list of approved food 443 
additives and their conditions of use. Food additives are listed on the basis of the categories 444 
of food to which they may be added to, with Category 8 covering processed and unprocessed 445 
meat. Food enzymes are covered separately by Regulation (EC) 1332/2008. 446 
In the United States, Title 9 of the Code of Federal Regulations (CFR) provides the rules 447 
governing animals, and animal products. It includes two groups of protein contributing 448 
ingredients: Group 1 includes ingredients of livestock or poultry origin from muscle tissue 449 
which are skeletal or found in the edible organs, with or without the accompanying and 450 
overlying fat, and the portions of bone, skin, sinew, nerve, and blood vessels which normally 451 
accompany the muscle tissue, not separated in the process of dressing, as well as meat by 452 
products; mechanically separated (species); and poultry products. Ingredients processed by 453 
hydrolysis, extraction, concentrating or drying are part of Group 2 Protein-Contributing 454 
Ingredients along with any other ingredient which contributes protein. An up-to-date list of 455 
substances considered as safe and suitable ingredients for the production of meat, poultry and 456 
egg products is published in a regularly revised directive from the USDA-FSIS, currently 457 
Revision 39, from January, 2017. The list includes beef protein as a food grade substance 458 
approved as generally recognized as safe (GRAS), for use in meat, poultry and egg products. 459 
Federal regulation (USDA-FSIS, 1999) lays down the rules and regulations for collection and 460 
processing of blood when intended for human consumption. 461 
Meat protein ingredients are considered non-allergenic and are generally “minimally 462 
processed”. Additionally, their nomenclature is more easily recognised. Although this can 463 
make them more consumer-friendly, it may also negatively affect consumer perception. Table 464 
3 summarizes the current legislative scenario in Europe, regarding the use of meat co-465 
products. 466 
6. Relevant technologies 467 
Traditional methods such as chemical precipitation, ultrafiltration, extrusion, lyophilisation, 468 
isoelectric solubilization-precipitation or solvent extraction are widely employed in order to 469 
extract and concentrate proteins and peptides from waste materials (Galanakis, 2015). 470 
Depending on the raw material, and the final application of the extract, one of these methods, 471 
or a combination of them, has to be selected. However, some of the methods above 472 
mentioned, may have a negative impact on the activity of the desired compounds, since heat 473 
treatment (for instance evaporation, pasteurization or extrusion) or denaturing chemicals 474 
(ethanol, strong acids or alkalis) might irreversibly affect the structure and chemical 475 
properties of the target compounds. In the particular case of proteins and peptides, negative 476 
processing effects are (Korhonen, Pihlanto-Leppäla, Rantamäki, & Tupasela, 1998): 477 
i) Heat treatment: destruction of heat sensitive peptides, cross linkages, protein 478 
denaturation  479 
 ii) pH: racemization, destruction of amino acids, risk of oxidation 480 
 iii) Membrane filtration: change in amino acid composition 481 
 iv) Storage: destruction of lysine and oxidation. 482 
These changes can lead to a loss of protein functionality, nutritive value or bioactivity; 483 
reducing the final value of the product and narrowing their field of application. In order to 484 
minimise or prevent such modifications, novel technologies are being developed. Such 485 
technologies usually overcome the negative impacts of thermal treatments and additionally, 486 
minimise significantly the amount, and hence the effect, of solvents and reagents employed 487 
for protein/peptide extraction.   488 
Most promising and emerging technologies for protein extraction are those based on 489 
ultrasounds (Kadam, Tiwari, Álvarez, & O'Donnell, 2015); pulsed electric fields (PEF) 490 
(Soliva-Fortuny, Balasa, Knorr, & Martín-Belloso, 2009); high hydrostatic pressures (HHP) 491 
(Li, Zhu, Zhou, & Peng, 2012); sub-critical water hydrolysis (SWH) (Marcet, Alvarez, 492 
Paredes, & Diaz, 2016); or laser ablation  (Boutinguiza et al., 2007). Among these 493 
techniques, ultrasounds and PEF have been reported to produce negligible changes in protein 494 
composition and structure (Chandrapala, Zisu, Palmer, Kentish, & Ashokkumar, 2011; 495 
Garde-Cerdán, Arias-Gil, Marsellés-Fontanet, Ancín-Azpilicueta, & Martín-Belloso, 2007). 496 
On the other hand, HHP and SWH, can produce drastic changes in protein structure as non-497 
reversible unfolding or hydrolysis (Smeller, 2002). Other technologies which hold potential 498 
for these products include aqueous two phase extraction, foam mat drying, and others 499 
reported by Galanakis (2012). Table 4  presents how, through the application of currently 500 
available technologies, is possible to obtain high added-value products from the various co-501 
products generated by the meat industry. 502 
There is little evidence of the application of many of these emerging technologies for 503 
extracting value from meat co-products. More effort has been seen in optimizing the use of 504 
these emerging technologies on vegetables, seaweeds and dairy products. There clearly is a 505 
pressing need to examine the relevance of transferring these developments into the meat 506 
sector in terms for example of both recovery yields and impact on functionality of final 507 
product.  508 
 509 
7. Conclusions  510 
Opportunities clearly exist for extracting additional value from meat processing chains. As 511 
well as ensuring optimal use of such a protein rich material this approach also supports 512 
sustainable practices across the sector sector and will be increasingly necessary in a world of 513 
growing demand and constrained resources. Science and technology driven approaches must 514 
be coupled with market, legislative and consumer knowledge for successful 515 
commercialisation of the downstream products.  516 
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Tables 867 
Table 1: Total protein content (% wet basis), individual essential amino acids (g/100 g protein) and 868 
total essential amino acids (%EAA) in selected offal across a number of species.  869 
Product Specie Prot. (%) Lys Met Trp 
% 
EAA 
 
Blood Cattle 
Porcine 
17-18 
18.5 
9.7 
9.0 
2.4 
2.3 
- 
1.5 
60.6 
58 
Brain Cattle 
Porcine  
Sheep 
10.5 
10.3 
12.3 
6.0 
7.8 
6.4 
2.1 
2.0 
2.0 
4.7 
4.2 
1.1 
42.8 
46.8 
42.8 
Heart Cattle 
Porcine  
Sheep 
17 
17 
18 
8.2 
8.3 
7.5 
2.6 
2.6 
2.2 
1.1 
1.2 
1.1 
47.1 
47.7 
43.8 
Kidney Cattle 
Porcine  
Sheep 
15.3 
15.4 
18.0 
6.6 
7.2 
6.5 
2.1 
2.1 
2.0 
1.4 
1.3 
1.4 
45.2 
48.0 
43.9 
Liver Cattle 
Porcine  
Sheep 
21 
19 
20.3 
6.9 
7.7 
5.4 
2.5 
2.5 
2.1 
1.4 
1.4 
1.2 
49.1 
48.9 
42.7 
Lung Cattle 
Porcine  
Sheep 
17 
15 
12.5 
7.1 
7.3 
6.5 
2.0 
1.6 
1.8 
0.9 
0.9 
0.9 
41.5 
37.8 
40.6 
Spleen Cattle 
Porcine  
Sheep 
19 
17.9 
17.2 
7.2 
7.5 
7.7 
1.8 
1.8 
1.9 
1.0 
1.0 
1.1 
48.0 
41.9 
48.5 
Tongue Cattle 
Porcine  
Sheep 
17.1 
16.3 
15.3 
7.7 
8.2 
7.1 
2.1 
2.2 
2.1 
0.8 
1.2 
1.0 
45.8 
40.2 
40.4 
Connective tissue 
collagen 
 85% 3.5 0.7 0.0 11.97 
Data from Venegas, 1996. 870 
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Table 2: Summary of bioactive compounds from meat sources 878 
Compound Concentration 
(mg/g) 
Biological function 
Conjugated 
linoleic acid 
3-8 (beef fat) Reduced risk of colorectal cancer and diabetes, 
antioxidant, immunomodulatory.  
 
Carnosine 2.7  
(pork shoulder) 
Antioxidant 
Anserine nd Antioxidant, metal chelating 
 
L-carnitine 1.3 (beef tight) Lowing-cholesterol, calcium absorption, prevention 
of muscle myopathy 
Glutathione 0.12-0.26  
(beef muscle) 
Antioxidant, defence against toxicological and 
pathological processes 
Taurine 0.77 (beef muscle) Eye health, preventing heart disease, essential in 
some stages(lactation or immune challenge)  
Coenzyme Q10 0.02 (beef muscle) Antioxidant 
Creatine 3.5 (beef muscle) Enhancing muscle performance 
*Adapted from (Arihara and Ohata (2008)) 879 
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 890 
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 892 
 893 
Table 3: Main Regulations and Directives regarding the use of meat processing co-products 894 
in Europe 895 
Scope Reference Short description 
General 
Reg.(EC) 999/2001 rules for the prevention, control and eradication of 
certain transmissible spongiform encephalopathies in 
animals 
Directive 2008/98/EC  concepts and definitions related to waste managament, 
such as definitions of waste, recycling, recovery 
Directive 2008/1/EC  integrated pollution prevention and control 
Reg.(EC) 1069/2009 health rules as regards animal by-products and derived 
products not intended for human consumption 
For human 
consumption 
“Hygiene Package"  
 Reg.(EC) 852/2004 
 Reg.(EC) 853/2004 
 Reg.(EC) 854/2004  
 
on the hygiene of foodstuffs;  
specific hygiene rules for food of animal origin;  
specific rules for products of animal origin intended for 
human consumption 
Reg.(EC) 1169/2011  provision of food information to consumers 
Reg.(EC) 609/2013  food intended for infants and young children, food for 
special medical purposes, and total diet replacement for 
weight control 
Reg.(EC) 1333/2008  approved food additives and their conditions of use 
Specific 
applications 
Reg.(EC) 1332/2008  enzymes used in food 
Directive 76/768/EEC  cosmetic products 
Directive 90/385/EEC  medical implants 
Directive 2003/32/EC  medical devices 
Directive 89/79/EC  In vitro diagnostic medical devices 
Directive 2001/82/EC  vet medical products 
Directive 2001/83/EC  medicinal products 
 896 
 897 
 898 
 899 
 900 
 901 
 902 
 903 
 904 
 905 
Table 4: Examples of revalorising techniques for adding value to several meat co-products. 906 
Product Revalorizing techniques High added-value products 
Liver Enzymatic hydrolysis Antioxidant peptides 
Heart Isoelectric solubilization/precipitation 
 
Phosphate buffer washing 
High value protein with low ash, fat 
and cholesterol 
Myofibrillar concentrate as  
texturizing    
Skin Collagen recovery 
 
 
Enzymatic hydrolysis and 
chromatographic purification 
Collagen hydrolysis 
Barrier membrane, drug delivery, 
fibroblast scaffolds, bioengineered 
tissues 
Antioxidant peptides and liver 
protectors 
Antioxidant activity, antimicrobial 
properties antihypertensive, 
biomimetic tissue 
Blood Enzymatic hydrolysis 
 
 
 
Chemical hydrolysis 
 
Ethanol precipitation 
 
High pressure treatment 
 
Subcritical water hydrolysis 
Antioxidant, antibacterial, 
antihypertensive or iron-binding 
peptides 
 
Pre-digested peptides for animal and 
pet food 
Purified protein as food ingredient  
Peptides and biopreserved blood  
Amino acid and peptides production 
Bone Subcritical water 
Alkaline extraction 
Hydroxyapatite and collagen 
New kind of sausages 
Lung Isoelectric solubilization - 
precipitation and membrane filtration 
Protein concentrates with good 
functional properties 
Feathers 
and hair 
Keratinolytic bacteria fermentation 
and enzymatic hydrolysis 
 
 
Keratinolytic protease production, 
culture medium, soil assessment, 
separation membranes 
*Adapted from Mullen, Álvarez, Pojić, Hadnadev, & Papageorgiou, 2015. 907 
